Tonix Pharmaceuticals Holding Corp. (TNXP) Social Stream
TONIX PHARMACEUTICALS HOLDING CORP (TNXP) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering TNXP.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-03-31 | 1 | $2 | $1.5 | $1.75 | $0.282 | 520.57% |
| 2022-04-19 | 1 | $2 | $0.6 | $1.366 | $0.282 | 384.4% |
| 2022-05-25 | 1 | $63.897 | $10 | $40.606 | $0.282 | 14299.29% |
| 2022-05-31 | 1 | $63.897 | $10 | $29.965 | $0.282 | 10525.89% |
| 2022-09-12 | 1 | $10 | $8 | $9 | $0.282 | 3091.49% |
| 2022-12-05 | 1 | $10 | $6 | $8 | $0.282 | 2736.88% |
| 2023-01-12 | 1 | $10 | $6 | $7.5 | $0.282 | 2559.57% |
| 2023-04-14 | 1 | $6.5 | $6 | $6.333 | $0.282 | 2145.74% |
| 2023-05-09 | 1 | $40.625 | $40.625 | $40.625 | $0.282 | 14306.03% |
| 2023-05-30 | 1 | $40.625 | $6.5 | $29.25 | $0.282 | 10272.34% |
| 2023-06-02 | 1 | $40.625 | $6.5 | $21.708 | $0.282 | 7597.87% |
| 2023-06-21 | 1 | $18 | $6.5 | $12.833 | $0.282 | 4450.71% |
| 2023-06-27 | 1 | $18 | $10 | $14 | $0.282 | 4864.54% |
| 2023-07-06 | 1 | $18 | $10 | $14.333 | $0.282 | 4982.62% |
| 2023-07-25 | 1 | $18 | $6.5 | $13.166 | $0.282 | 4568.79% |
| 2023-08-01 | 1 | $15 | $6.5 | $9.833 | $0.282 | 3386.88% |
| 2023-09-06 | 1 | $15 | $8 | $11 | $0.282 | 3800.71% |
| 2023-09-26 | 1 | $10 | $8 | $8.666 | $0.282 | 2973.05% |
| 2023-12-21 | 1 | $10 | $3 | $7 | $0.282 | 2382.27% |
| 2023-12-22 | 1 | $10 | $3 | $6.333 | $0.282 | 2145.74% |
Price Target Last Issued September 26, 2023
The Trend in the Analyst Price Target
TNXP's average price target has moved up $2.08 over the prior 29 months.
Over the past 49 weeks, TNXP's average upside potential has been 1,553.69%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-05-01 | 1 | 6.500 | 6.5 | 6.500 | 3.00 | 116.67% |
| 2023-05-01 | 1 | 6.500 | 6.5 | 6.500 | 0.48 | 1254.17% |
| 2023-05-30 | 1 | 40.625 | 6.5 | 29.250 | 1.63 | 1694.48% |
| 2023-07-06 | 1 | 18.000 | 10.0 | 14.333 | 1.55 | 824.71% |
| 2023-09-06 | 1 | 15.000 | 8.0 | 11.000 | 0.92 | 1095.65% |
TNXP Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
Over the past 52 weeks, TNXP's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for TNXP as an investment opportunity.
- In terms of how TONIX PHARMACEUTICALS HOLDING CORP fares relative to all US stocks, note that its number of analysts covering the stock is higher than nearly none of that group.
- In the context of all US stocks, TONIX PHARMACEUTICALS HOLDING CORP's upside potential (average analyst target price relative to current price) is higher than 2276.04% of them.
- TONIX PHARMACEUTICALS HOLDING CORP's variance in analysts' estimates is lower than -1336.78% of stocks in the small market cap category.
- TNXP has a higher average analyst price target than 551.53% of Healthcare stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to TONIX PHARMACEUTICALS HOLDING CORP are FBIO, ASMB, and KURA.
View All Top Stocks by Price Target
What is the outlook for TNXP? Use POWR Ratings for clearer insight into price direction.